Inhaled nitric oxide in term and preterm infants

Journal of Perinatology : Official Journal of the California Perinatal Association
K Sekar

Abstract

Nitric oxide (NO) is a gas that has potent vasodilator properties. It can be administered via inhalation in situations where NO production is impaired and results in vasodilatation of the pulmonary capillaries. In term infants, the administration of inhaled NO, at a dose of 20 parts per million, may reduce the need for extracorporeal membrane oxygenation by reducing pulmonary vascular resistance and improving oxygenation. Inhaled NO is an approved therapy in term babies with severe hypoxemic respiratory failure. In premature infants, inhaled NO may increase bleeding time and decrease platelet aggregation resulting in an increased risk for intraventricular hemorrhage. Early administration of inhaled NO may also potentially decrease the risk for developing chronic lung disease in premature infants. However, since studies show conflicting results, inhaled NO should only be used in premature neonates following investigational review board approved protocols.

References

Oct 1, 1976·The Journal of Pediatrics·D L LevinA M Rudolph
Dec 1, 1987·Proceedings of the National Academy of Sciences of the United States of America·L J IgnarroG Chaudhuri
Jul 1, 1986·The Journal of Clinical Investigation·F Murad
Aug 1, 1987·Environmental Health Perspectives·K Yoshida, K Kasama
Jun 26, 1993·Lancet·M HögmanG Hedenstierna
Feb 27, 1997·The New England Journal of Medicine·UNKNOWN Neonatal Inhaled Nitric Oxide Study Group
Feb 14, 1998·Archives of Disease in Childhood. Fetal and Neonatal Edition·N V SubhedarN J Shaw
Oct 22, 2002·American Journal of Physiology. Lung Cellular and Molecular Physiology·Philip W ShaulDonald C McCurnin
Dec 4, 2003·The New England Journal of Medicine·Michael D SchreiberPimol Srisuparp
Mar 5, 2005·Pediatric Research·Isabelle HamonJean-Michel Hascoet
Mar 10, 2005·The Journal of Pediatrics·J M HascoetP Onody
Jul 8, 2005·The New England Journal of Medicine·Krisa P Van MeursUNKNOWN Preemie Inhaled Nitric Oxide Study
Jul 8, 2005·The New England Journal of Medicine·Karen K L MestanMichael D Schreiber

❮ Previous
Next ❯

Citations

May 2, 2009·Journal of Applied Physiology·William J PearceThomas M Lincoln
Jan 24, 2007·Physiological Reviews·Pál PacherLucas Liaudet
Oct 20, 2009·Nanomedicine : Nanotechnology, Biology, and Medicine·Tad Hogg, Robert A Freitas
Mar 19, 2009·ASAIO Journal : a Peer-reviewed Journal of the American Society for Artificial Internal Organs·Amerik C de MolKian D Liem

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

Expert Review of Anticancer Therapy
Ciaran HillHitendra R H Patel
Science
George M Whitesides, Bartosz Grzybowski
Current Opinion in Biotechnology
J L West, N J Halas
Behavioural Brain Research
S J BolanowskiFrancis McGlone
© 2022 Meta ULC. All rights reserved